S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:CLLS

Cellectis Earnings Date, Estimates & History

$18.19
-1.12 (-5.80 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$17.00
Now: $18.19
$19.29
50-Day Range
$19.31
MA: $26.76
$33.25
52-Week Range
$7.32
Now: $18.19
$34.71
Volume775,323 shs
Average Volume454,703 shs
Market Capitalization$772.82 million
P/E RatioN/A
Dividend YieldN/A
Beta2.59

Earnings

Cellectis (NASDAQ:CLLS) Earnings Information

Cellectis last released its quarterly earnings data on March 4th, 2021. The biotechnology company reported ($0.95) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.01) by $0.06. Cellectis has generated ($2.41) earnings per share over the last year. Cellectis has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.

Cellectis Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Cellectis (NASDAQ:CLLS) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20211$1.93$1.93$1.93

Cellectis (NASDAQ CLLS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/5/2021
(Estimated)
       
3/4/2021Q4($1.01)($0.95)($0.95)Transcript
11/5/20209/30/2020($0.69)($0.71)($0.71)$2.25 million$9.24 millionTranscript
8/5/2020Q2 2020($0.73)($0.76)($0.76)$2.37 million$4.62 millionN/A
5/6/20203/31/2020($0.59)$0.47$0.47$21.07 million$51.91 millionTranscript
3/4/202012/31/2019($0.84)($0.88)($0.88)$3.87 million$6.34 millionTranscript
11/6/2019Q3 2019($0.89)($0.38)($0.38)$1.40 million$10.21 millionN/A
8/6/2019Q2($0.61)($0.79)($0.79)$3.45 million$2.93 millionN/A
5/7/2019Q1 2019($0.63)($0.36)($0.36)$3.70 million$3.43 millionN/A
3/11/2019Q4 2018($0.67)($0.53)($0.53)$7.46 million$3.08 millionN/A
11/13/2018Q3 2018($0.62)($0.54)($0.54)$10.00 million$2.19 millionN/A
8/1/2018Q2($0.6230)($0.17)($0.17)$9.43 million$8.34 millionN/A
5/7/2018Q1($0.6980)($0.71)($0.71)$9.53 million$8.07 millionN/A
3/12/2018Q4 2017($0.64)($0.76)($0.76)$10.10 million$6.91 millionN/A
11/13/2017Q3 2017($0.57)($0.73)($0.73)$10.56 million$7.25 millionN/A
8/2/2017Q2 2017($0.59)($0.74)($0.74)$10.30 million$8.96 millionN/A
5/9/2017Q1 2017($0.56)($0.56)($0.56)$9.52 million$10.30 millionN/A
3/6/2017Q4 2016($0.34)($0.38)($0.38)$9.65 million$13.02 millionN/A
11/22/2016Q3 2016($0.90)($0.40)($0.40)$9.74 million$12.62 millionN/A
9/8/2016Q2 2016($0.64)($0.20)($0.20)$8.02 million$20.49 millionN/A
5/11/2016Q1 2016($0.35)($0.92)($0.92)$7.78 million$10.48 millionN/A
3/14/2016Q4 2015($0.06)$0.25$0.25$5.72 million$31.97 millionN/A
11/16/2015Q215($0.43)($0.40)($0.40)$1.23 million$11.10 millionN/A
9/8/2015Q2 2015($0.64)($0.70)($0.70)$2.37 million$8.85 millionN/A
6/9/2015Q1 2015$0.26$0.26$10.29 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.